Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

50.86
Delayed Data
As of 2:46pm ET
 -0.1601 / -0.31%
Today’s Change
26.02
Today|||52-Week Range
78.72
-1.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues105.4M33.9M34.7M25.2M
 
 
 
 
 
Depreciation And Amortization2.9M2.7M2.4M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income--31.2M----
 
 
General Expenses72.0M58.1M77.7M122.4M
 
 
 
 
 
Research And Development58.7M46.1M54.9M79.8M
 
 
 
 
 
Total Operating Expenses74.8M60.8M80.1M124.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income30.6M-26.8M-45.4M-99.4M
 
 
 
 
 
Extraordinary Credit----37.5K0.00
 
 
Extraordinary Charge-----130.0K-130.0K
 
 
 
Interest Expense On Debt2.4M1.2M6.1M0.00
 
 
 
 
Other Expenses461.4K1.8M0.00-83.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.6M-26.2M-51.6M-98.4M
 
 
 
 
 
Income Taxes-2.3M0.000.00-4.7M
 
 
 
Preferred Dividend0.000.00-18.2M0.00
 
 
Net Income30.9M133.3M-48.2M-93.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.2M14.2M12.8M31.6M
 
 
 
 
 
Shares To Calculate EPS Diluted14.2M14.2M12.8M31.6M
 
 
 
 
 
 
Earnings Per ShareEPS--$9.40-$5.18-$2.97
 
 
 
 
EPS Diluted$2.18$9.40-$5.18-$2.97